Atorvastatin calcium plus amlodipine for the treatment of hypertension.

Item

http://www.wikidata.org/entity/Q38058827

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Atorvastatin calcium plus amlodipine for the treatment of hypertension.

@en

type

Item

label

Atorvastatin calcium plus amlodipine for the treatment of hypertension.

@en

prefLabel

Atorvastatin calcium plus amlodipine for the treatment of hypertension.

@en

P1476

Atorvastatin calcium plus amlodipine for the treatment of hypertension

@en

P2093

Jose L Zamorano

http://www.w3.org/2001/XMLSchema#string

P2860

Prediction of Coronary Heart Disease Using Risk Factor Categories

Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

P304

2673-2685

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.742064

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Delgado-Montero

P577

2012-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23140185

http://www.w3.org/2001/XMLSchema#string